Below you can see the diagram of the Drug Discovery Complex and the method of using and updating its databases.
The following diagrams demonstrate possible models of our collaboration with pharmaceutical companies, along with short explanations.
A pharmaceutical company passes patient’s clinical datasets to us. Then we investigates these datasets to form a list of suitable treatments and drugs and passes all of the information (both datasets and treatment recommendations) to the Pathway Cloud Intelligence algorithm. It analyzes the genetic features of the patient or a group of patients and chooses the best therapy and drugs for them.
A pharmaceutical company passes to us an uncategorized list of available drugs, and we examines it and passes to Pathway Cloud Intelligence. After investigation of the drugs and its components, Pathway Cloud Intelligence presents to the pharmaceutical company the most efficient drugs for treatment.
A pharmaceutical company sends to us an inquiry for prospective compounds, and OncoFinder Platform analyzes the characteristics of each compound and passes the results to Pathway Cloud Intelligence. After investigation of the compounds, Pathway Cloud Intelligence presents to the pharmaceutical company the most efficient compound combinations.